Table 1.
Demographics and clinical data.
| Total (N = 29) | |
|---|---|
| Age, median (IQR) | 27 (25–38) |
| Male, n (%) | 16 (55.1) |
| BMI, median (IQR) | 20.3 (19.2–21.9) |
| Symptom, n (%) | |
| cough | 13 (44.8) |
| sputum | 15 (51.7) |
| fever | 4 (13.8) |
| weight loss | 3 (10.3) |
| fatigue | 9 (31.0) |
| chest pain | 7 (24.1) |
| dyspnea | 3 (10.3) |
| hemoptysis | 3 (10.3) |
| others | 1 (3.4) |
| Chest CT finding, n (%) | |
| centrilobular | 9 (31.0) |
| consolidation | 11 (37.9) |
| cavity + centrilobular | 8 (27.6) |
| mass | 1 (3.4) |
| Extent of the disease in chest CT, the number of lobes (%) | |
| One lobe | 20 (69.0) |
| 2–3 lobes | 9 (31.0) |
| >3 lobes | 0 |
| Blood tests, median (IQR) | |
| WBC count (/µL) | 6990.0 (5750.0–8380.0) |
| Hemoglobin level (g/dL) | 13.8 (12.3–14.9) |
| Platelet count (×103/µL) | 292.0 (251.0–387.0) |
| Sputum exam, n (%) | |
| AFB smear, positive | 3 (10.3) |
| TB culture, positive | 22 (75.9) |
| sputum conversion | 22 (100.0) |
| QFT-GIT assay, median (IQR) | |
| Nil | 0.21 (0.13–0.28) |
| TB Ag | 9.47 (4.51–10.00) |
| mitogen | 10.00 (10.00–10.00) |
| TB Ag-Nil | 8.6 (4.2–10.00) |
| Extrapulmonary TB, n (%) | 1 (3.4) |